On-Demand Webcast

Share

Program Content

Activities

  • CD47 Therapy in MDS and AML
    Targeting CD47 in MDS and AML: An Emerging New Immunotherapy Approach
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 15, 2023

    Expires: August 14, 2024

Provided by

ProCE Banner

Supporters

This program has been supported by an independent educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.